Thus, for nonsense GRN mutations that result in NMD, read-through compounds may have promise, although no data has yet been published showing correction of downstream effects of progranulin deficiency by these compounds. This evidence concerns the gene GRN and hyperinsulinemic hypoglycemia, familial, 4.